Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Bipolar Disorder (BPD) in Pregnancy: Predictors of Morbidity
A completed clinical trial from Emory University investigates predictors of morbidity in bipolar disorder during pregnancy.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode [Phase 3]
Phase 3 clinical trial evaluating aripiprazole for Bipolar I disorder with a major depressive episode has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Study of Aripiprazole in Patients With a History of Bipolar Disorder [Phase 3]
Phase 3 study of aripiprazole in patients with a history of bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder [Phase 3]
Phase 3 study evaluating aripiprazole for acute symptoms of Bipolar I Disorder has completed, sponsored by Otsuka.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Aripiprazole in Patients With Acute Mania [Phase 3]
Phase 3 clinical trial of aripiprazole in acute mania has completed, according to a clinical trials update.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder [Phase 3]
A Phase 3 trial of aripiprazole for acute symptoms in bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode [Phase 3]
A Phase 3 clinical trial update for aripiprazole in adults with Bipolar I disorder experiencing a major depressive episode; the study status…
-
FDA approval · 2013-11-08FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol (carbamazepine) submitted by Novartis Pharmaceuticals Corporation. The approval updates…
-
FDA approval · 2013-11-08FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approves a supplemental application for Tegretol (carbamazepine) submitted by Novartis Pharmaceuticals Corporation, resulting in an upda…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Study of Aripiprazole in Patients With Bipolar I Disorder [Phase 3]
A Phase 3 study investigating aripiprazole in patients with Bipolar Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder [Phase 1]
Phase 1 trial evaluating potential drug-drug interaction between aripiprazole and lamotrigine in patients with bipolar disorder (bipolar I d…
-
CLINICAL_TRIALS withdrawal · 2013-11-08Clinical Trial Update: A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode [Phase 3]
This document reports the withdrawal of a Phase 3 trial evaluating aripiprazole for bipolar I disorder with a major depressive episode. The …
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Study of Aripiprazole in Patients With Acute Bipolar Mania [Phase 3]
A Phase 3 trial evaluating aripiprazole for acute bipolar mania has completed.
-
FDA approval · 2013-11-07FDA Approved: OLANZAPINE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
The FDA approved a supplemental application for OLANZAPINE from Jubilant Cadista Pharmaceuticals Inc. This is a routine regulatory action up…
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder
An update on the efficacy and safety of aripiprazole in patients with schizophrenia or bipolar disorder from a completed clinical trial.
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder [Phase 4]
Phase 4 trial evaluating Depakote ER for mania in children aged 6-12 with bipolar disorder; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar Disorder [Phase 4]
Aripiprazole was studied in a Phase 4 clinical trial for treating mania in children and adolescents with bipolar disorder, and the study sta…
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder [Phase 4]
Phase 4 clinical trial update evaluating Concerta for ADHD in youth and adults with Bipolar Disorder. The study has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder [Phase 4]
Phase 4 trial of ziprasidone for mania in children and adolescents with bipolar disorder has completed; the update summarizes pediatric effi…
-
FDA label_change · 2013-10-21FDA Approved: ZYPREXA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for ZYPREXA (olanzapine) from Eli Lilly and Company, resulting in labeling changes for the medic…
-
FDA approval · 2013-10-17FDA Approved: LAMOTRIGINE — Original Application (Actavis Pharma, Inc.)
FDA approved a generic lamotrigine product from Actavis Pharma under an Original Application (ANDA 200672).
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression [Phase 3]
A Phase 3 trial of lurasidone HCl for Bipolar I Depression has completed, and the results were posted in October 2013.
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD) [Phase 3]
Phase 3 trial evaluating quetiapine extended-release (XR) for bipolar disorder patients with comorbid generalized anxiety disorder; results …
-
CLINICAL_TRIALS trial_result · 2013-10-09Clinical Trial Update: Safety and Efficacy Study of Lithium for the Treatment of Pediatric Mania. [Phase 2, Phase 3]
This update reports the completion of a Phase 2/3 safety and efficacy study evaluating lithium for the treatment of mania in children and ad…
-
CLINICAL_TRIALS research · 2013-10-08Clinical Trial Update: Efficacy of Adjunctive Tianeptine in the Treatment of Bipolar Depression [Phase 3]
Phase 3 trial investigating adjunctive tianeptine for bipolar depression; status not reported.